SCHEMBL107003

SCHEMBL107003

C=C(CCCCCCCCCCCCCCCCC)OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.44
CES1 P23141 3/20 0.44
HSP90AA1 P07900 1/20 0.43
POLB P06746 1/20 0.42
POLA1 P09884 1/20 0.42
GPR84 Q9NQS5 7/20 0.42
PPARG P37231 7/20 0.42
PPARD Q03181 7/20 0.42
PPARA Q07869 7/20 0.42
HDAC11 Q96DB2 5/20 0.42
TSHR P16473 4/20 0.42
PTPN1 P18031 3/20 0.42
ALDH1A1 P00352 2/20 0.42
TLR2 O60603 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
FABP4 P15090 2/20 0.42
SLC22A6 Q4U2R8 1/20 0.42
SLC22A8 Q8TCC7 1/20 0.42
MEN1 O00255 1/20 0.42
ESR1 P03372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13176717 1.00 CES2 (0.44) CES2CES1HSP90AA1POLBPOLA1
SCHEMBL25541686 1.00 CES2 (0.44) CES2CES1HSP90AA1POLBPOLA1
SCHEMBL11461398 1.00 CES2 (0.44) CES2CES1HSP90AA1POLBPOLA1
SCHEMBL1142871 1.00 CES2 (0.44) CES2CES1HSP90AA1POLBPOLA1
SCHEMBL1142715 1.00 CES2 (0.44) CES2CES1HSP90AA1POLBPOLA1
SCHEMBL8070766 1.00 CES2 (0.44) CES2CES1HSP90AA1POLBPOLA1
SCHEMBL1142387 1.00 CES2 (0.44) CES2CES1HSP90AA1POLBPOLA1
SCHEMBL4215862 0.97
SCHEMBL7042903 0.90
SCHEMBL16003068 0.89 ALDH1A1 (0.38) POLBPOLA1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER 2011-02-17 US claimed
EP-2201156-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS Busch, Rainer (US) 2010-06-30 EP claimed
WO-2009035689-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2009-03-19 WO claimed
WO-2018094269-A1 COMPOSITIONS FORMED FROM PLANT EXTRACTS AND METHODS OF PREPARATION THEREOF APEEL TECHNOLOGY, INC. (US) 2018-05-24 WO disclosed
EP-2201156-B1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2013-10-02 EP disclosed
US-8444845-B2 Biofuel composition and manufacturing process BUSCH RAINER (US) 2013-05-21 US disclosed
EP-2426191-A1 Process for the homogenous hydrogenation of (poly)unsaturated hydrocarbons Cognis IP Management GmbH (DE) 2012-03-07 EP disclosed
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER 2011-02-17 US disclosed
EP-2201156-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS Busch, Rainer (US) 2010-06-30 EP disclosed
WO-2009035689-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2009-03-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS FASN, SCD, ADH1A CES2 388/4885CES1 179/4885HSP90AA1 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.